Cagan Gurer, Ph.D.
Affiliations: | 2004 | Columbia University, New York, NY |
Area:
Molecular BiologyGoogle:
"Cagan Gurer"Parents
Sign in to add mentor| Jeremy Luban | grad student | 2004 | Columbia | |
| (Identification of HIV -1 Gag interacting host factors.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ye X, Waite JC, Dhanik A, et al. (2020) Endogenous retroviral proteins provide an immunodominant but not requisite antigen in a murine immunotherapy tumor model. Oncoimmunology. 9: 1758602 |
| Waite JC, Wang B, Haber L, et al. (2020) Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy. Science Translational Medicine. 12 |
| Gao J, Van Meter M, Lopez SH, et al. (2019) Therapeutic targeting of Notch signaling and immune checkpoint blockade in a spontaneous, genetically-heterogeneous mouse model of T-cell acute lymphoblastic leukemia. Disease Models & Mechanisms |
| Wang B, Zhang W, Jankovic V, et al. (2018) . Science Immunology. 3 |
| Herndler-Brandstetter D, Shan L, Yao Y, et al. (2017) Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proceedings of the National Academy of Sciences of the United States of America |
| Yu H, Borsotti C, Schickel JN, et al. (2017) A novel humanized mouse model with significant improvement of class- switched, antigen-specific antibody production. Blood |
| Deng K, Pertea M, Rongvaux A, et al. (2015) Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature. 517: 381-5 |
| Crawford A, Vazzana K, VanValkenburgh J, et al. (2015) Abstract A193: Fully human bispecific antibodies induce potent anti-tumor effects against prostate tumors in mice Molecular Cancer Therapeutics. 14 |
| Strowig T, Gurer C, Ploss A, et al. (2009) Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. The Journal of Experimental Medicine. 206: 1423-34 |
| Gurer C, Strowig T, Brilot F, et al. (2008) Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 112: 1231-9 |